Back to Search
HAGEN KENNECKE, MD, MHA, FRCPC
MD, MHA, FRCPC
Medical Oncology Physician
NPI: 1578090270IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
60729732(WA)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD203393(OR)
Education
DALHOUSIE UNIVERSITY, FACULTY OF MEDICINE
Class of 1997
Research & Publications (13)
Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.
PMID 19273701·J Clin Oncol·2009
2-rct
Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole.
PMID 19237634·J Clin Oncol·2009
8-other
Intervals longer than 20 weeks from breast-conserving surgery to radiation therapy are associated with inferior outcome for women with early-stage breast cancer who are not receiving chemotherapy.
PMID 19018080·J Clin Oncol·2009
8-other
Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence.
PMID 19082705·Breast Cancer Res Treat·2009
8-other
Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
PMID 18194560·Breast Cancer Res·2008
2-rct
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
PMID 17912629·Breast Cancer Res Treat·2008
8-other
Predictors of positive radial margin status in a population-based cohort of patients with rectal cancer.
PMID 18454185·Curr Oncol·2008
8-other
Trends in chemotherapy utilization for colorectal cancer.
PMID 19036691·Clin Colorectal Cancer·2008
8-other
SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
PMID 18458674·Br J Cancer·2008
8-other
Risk of early recurrence among postmenopausal women with estrogen receptor-positive early breast cancer treated with adjuvant tamoxifen.
PMID 18286526·Cancer·2008
8-other
Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen.
PMID 17030545·Ann Oncol·2007
8-other
Management and outcomes of isolated axillary node recurrence in breast cancer.
PMID 16983030·Arch Surg·2006
8-other
Benefit of Paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer.
PMID 14645445·J Clin Oncol·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1130 NW 22ND AVE STE 150
PORTLAND, OR 97210 - Phone
- (971) 262-9600
Quick Facts
- NPI
- 1578090270
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 29
- Publications
- 13
Are you this provider?
Claim Your Profile